Literature DB >> 6418259

The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.

A Ebringer.   

Abstract

The association of HLA-B27 with ankylosing spondylitis (AS) can be explained by a cross-tolerance hypothesis, which suggests that Gram-negative bacteria, such as Klebsiella, possess antigens which resemble HLA-B27. Experimental studies with human tissue-typing sera and rabbit anti-Klebsiella sera would appear to be compatible with this hypothesis. Clinical studies indicate that faecal Klebsiella can be isolated more readily from AS patients during active phases of the disease, when this is defined either clinically, with or without uveitis, or biochemically by elevation in ESR and C-reactive protein levels. The cross-tolerance hypothesis proposes that ankylosing spondylitis is a reactive arthritis following infection by Gram-negative bacteria and tissue damage is produced by antibacterial antibody binding to cross-reacting self-antigens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418259     DOI: 10.1093/rheumatology/xxii.suppl_2.53

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  28 in total

1.  Measurement of HLA class I expression in ankylosing spondylitis.

Authors:  P Creamer; J Edmonds; J Sullivan; S Matthews
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Rheumatoid arthritis as an infectious disease.

Authors:  A Ebringer
Journal:  BMJ       Date:  1991-08-31

Review 3.  Acute anterior uveitis and HLA-B27.

Authors:  P J Derhaag; T E Feltkamp
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

Review 4.  The heat shock protein response and its role in inflammatory disease.

Authors:  V R Winrow; L McLean; C J Morris; D R Blake
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

5.  Ig A antibodies to klebsiella in ankylosing spondylitis.

Authors:  O Ardiçoğlu; M B Atay; H Ataoğlu; N Etiz; H Ozenci
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

6.  Trauma and seronegative spondyloarthropathy: report of two more cases of peripheral arthritis precipitated by physical injury.

Authors:  I Olivieri; G Gemignani; C Christou; G Pasero
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

Review 7.  Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.

Authors:  I Bjarnason; T J Peters
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

8.  Ankylosing spondylitis, HLA-B27, and klebsiella.

Authors:  A F Geczy
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

9.  Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.

Authors:  L E McGuigan; J K Prendergast; A F Geczy; J P Edmonds; H V Bashir
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

10.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.

Authors:  C M Higgins; T Lund; M E Shipley; A Ebringer; M Sadowska-Wroblewska; R K Craig
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.